Your browser doesn't support javascript.
loading
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.
Buschow, Sonja I; Ramazzotti, Matteo; Reinieren-Beeren, Inge M J; Heinzerling, Lucie M; Westdorp, Harm; Stefanini, Irene; Beltrame, Luca; Hato, Stanleyson V; Ellebaek, Eva; Gross, Stefanie; Nguyen, Van Anh; Weinlich, Georg; Ragoussis, Jiannis; Baban, Dilair; Schuler-Thurner, Beatrice; Svane, Inge M; Romani, Nikolaus; Austyn, Jonathan M; De Vries, I Jolanda M; Schuler, Gerold; Cavalieri, Duccio; Figdor, Carl G.
Afiliação
  • Buschow SI; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ramazzotti M; Department of Gastroenterology and Hepatology, Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands.
  • Reinieren-Beeren IMJ; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
  • Heinzerling LM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Westdorp H; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Stefanini I; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Beltrame L; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
  • Hato SV; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Ellebaek E; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gross S; CCIT, Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Nguyen VA; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Weinlich G; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ragoussis J; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Baban D; Genomics Group, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Schuler-Thurner B; Current address: McGill University and Genome Quebec Innovation Centre, McGill University, Quebec, Canada.
  • Svane IM; Genomics Group, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Romani N; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Austyn JM; CCIT, Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • De Vries IJM; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Schuler G; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Cavalieri D; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Figdor CG; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Oncotarget ; 8(40): 67439-67456, 2017 Sep 15.
Article em En | MEDLINE | ID: mdl-28978044
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article